Skip to content
HabitSeek
Back to results

Consider magnesium supplementation for sleep

Consider an oral magnesium supplement for sleep only after weighing the uncertain evidence and checking whether it is appropriate for you.

At a glance

  • Evidence: Some trials show modest subjective sleep improvements, but the latest magnesium-only review finds inconsistent, low-to-very-low-certainty evidence.Sleep quality and insomnia symptoms · Very limited certainty · Randomized intervention
  • What’s uncertain: A small formulation-specific effect does not establish routine insomnia treatment or benefit from every magnesium product.
  • First step: Review dietary need and read the elemental magnesium amount on the label.
  • Before you try it: Seek advice with kidney impairment or regular medicines. All precautions

Takeaway

A 2026 systematic review of magnesium-only randomized trials found mixed results and low to very low certainty, with no support for routine use as an insomnia treatment. A prior review in older adults reported shorter sleep-onset latency, but its three small trials had important risk-of-bias concerns. This entry does not establish a preferred formulation, dose, or group likely to benefit.

Magnesium tabletsDiscussed by3 peopleView statements ↓
NutritionSleepUnder 10 min · Easy · Low
Reviewed Oct 15, 2026
Save

Scientific evidence

What the research shows

Outcome assessments based on research, including its uncertainties and limitations.

Sleep quality and insomnia symptoms

Finding: Mixed evidenceCertainty: Very limitedstudies disagree, or the effect depends on who is studied

Evidence basis: randomised trials

Some magnesium trials report modest subjective sleep benefits, but the overall evidence remains inconsistent.

Population: Adults with insomnia or self-reported poor sleep, with varying ages, baseline intake, magnesium formulations and outcome measures.

Research details

Summary

The 2026 magnesium-only review included 12 main sleep trials and found inconsistent subjective, EEG, actigraphy and wearable results, with low to very low certainty. A 155-person bisglycinate trial found a small four-week insomnia-severity benefit (Cohen's d = 0.2; p = 0.049). An older three-trial review reported shorter sleep-onset latency, but all studies had moderate-to-high risk of bias. This supports acknowledging research and possible modest effects, not recommending routine insomnia treatment.

Why this certainty

Rated Very limited to reflect the most recent review's low-to-very-low formal certainty, inconsistent endpoints and modest formulation-specific trial effect. A statistically significant small trial does not override the broader synthesis.

Limitations

The positive bisglycinate trial was short and largely subjective; its low-intake subgroup was exploratory. Different formulations and populations are not interchangeable, and older trials are small and biased. Correcting deficiency and treating chronic insomnia are separate decisions.

Effect estimate

Bisglycinate trial: Cohen's d = 0.2 for four-week insomnia-severity change; older review sleep-onset MD -17.36 min (95% CI -27.27 to -7.44), low/very-low certainty.

Sources for this outcome:

What people say

Who discusses this?

Public statements, with positions specific to each source and topic. These views do not determine the scientific evidence assessment.

What the research shows ↑

Practical steps and precautions

How to try it

  1. Review diet and any clinical reason for supplementation rather than treating magnesium as a routine insomnia therapy.
  2. Read the amount of elemental magnesium, not just the weight of magnesium glycinate, citrate or threonate. Include magnesium from other supplements, antacids and laxatives in the review.
  3. Formulations differ in absorption and gastrointestinal effects. Evidence for one form or a multi-ingredient product does not prove that every magnesium product improves sleep or cognition; free glycine is a separate intervention.
  4. If you choose a product after reviewing suitability, keep other sleep routines stable, assess whether it is useful and stop if troublesome side effects occur.

Precautions

  • Magnesium supplements can interact with some medicines and may cause gastrointestinal effects; ask a pharmacist if you take regular medication.
  • People with kidney impairment should seek medical advice before supplementing because magnesium can accumulate.

References

Magnesium Supplementation for Sleep in Adults: A Systematic Review of Randomized Controlled Trials

Lopresti AL, Smith SJ, Drummond PD · Journal of Dietary Supplements · 2026

Systematic review of randomized controlled trials of oral magnesium for sleep-related outcomes in adultsVerified from abstract
Open original source

Magnesium Bisglycinate Supplementation in Healthy Adults Reporting Poor Sleep: A Randomized, Placebo-Controlled Trial.

Schuster J, Cycelskij I, Lopresti A, Hahn A. · Nature and science of sleep · 2025

Four-week randomized double-blind placebo-controlled magnesium-bisglycinate trial in 155 adults reporting poor sleepVerified from abstract
Open original source

Oral magnesium supplementation for insomnia in older adults: a Systematic Review & Meta-Analysis

Mah J, Pitre T · BMC Complementary Medicine and Therapies · 2021

Systematic review and meta-analysis of randomized trials in older adultsVerified from abstract
Open original source

The Role of Magnesium in Sleep Health: a Systematic Review of Available Literature

Arab A, Rafie N, Amani R, Shirani F · Biological Trace Element Research · 2023

Systematic review of observational and interventional studies of magnesium and sleep in adultsVerified from abstract
Open original source

Background and safety references

These support context and precautions; they are separate from assessed outcome sources.

Magnesium - Fact Sheet for Health Professionals

NIH Office of Dietary Supplements · NIH Office of Dietary Supplements · 2026

Government reportInstitutional guidance page retrieved and read on 2026-10-03; no randomized evaluation of the proposed behaviour is implied.Verified from full textBackground or safety reference
Open original source

Community

Discussion

Have you tried this? What helped or made it difficult?

Reader experiences are separate from the scientific evidence. Explore all discussions

No discussions yet.

Be the first to ask a question or share your experience.

Sign in to vote or join the discussion.

Related habits

Explore other habits in a shared category. Each has its own evidence and precautions.

Editorial history and review method

Revision 6 · Approved for publication · Codex (bounded source check; site-owner publication authorization)

Prepared and checked with AI. Publication approval does not imply independent expert review. Request a correction.

Adds magnesium as a Basic entry with cited background evidence and no outcome verdict. The 2026 review is recent and includes authors with financial or investigator ties noted in disclosures; recheck the review’s abstract, conflicts, and conservative framing before approval. Europe PMC lookup returned empty results in this runtime, so source facts were checked against retrieved PubMed or journal records; recheck the source metadata and access status before approval. October 3 video follow-up: Expanded elemental-magnesium labels and formulation limits using current NIH guidance. Basic coverage remains: no assessed outcome or cognition claim was invented. Verify interaction timing and renal precautions against individual products. Publication release 2026-10-04: site owner authorized a bounded AI audit and release of this exact revision. See docs/release-audit-2026-10-04.md for source-check findings and limits. No independent health-professional or peer review is claimed. Category migration 2026-10-04: removed the separate goals field; categories: Nutrition, Sleep → Nutrition, Sleep. Research assessments, sources, guidance, precautions, and evidence review dates are unchanged. This revision awaits publication approval; no new evidence review is claimed. Publication approval 2026-10-04: site owner explicitly accepted all current category-migration revisions for deployment and requested that remaining limitations be retained in docs/content-review-backlog.md. Approval applies to this exact content revision. No new evidence review, independent expert review, or clinical validation is claimed; existing precautions and disclosures remain in effect. Discovery audit 2026-10-10: added familiar search aliases. Outcome assessments, evidence sources, practical guidance, precautions and evidence-review date are unchanged. Formulation aliases identify the topic covered, not an endorsement or a new effectiveness claim. This exact revision awaits publication approval. Publication approval 2026-10-10: site owner answered 'Approve and publish' to the question explicitly covering these eight naming/search revisions and deployment to habitseek.com. Approval applies to this exact revision. Evidence assessments, guidance, precautions and scientific review dates were unchanged by the discovery audit. This is publication approval, not independent expert or clinical validation. The 15 later supplement drafts are outside this approval. Requested literature follow-up, 2026-10-15: Promoted the existing Basic entry to an explicit sleep assessment; retained the latest 12-trial review and added the 155-person bisglycinate trial. The overall conclusion remains mixed at Very limited certainty, with kidney/interaction precautions retained. Search scope, retrieved abstracts and limitations: docs/research/evidence-order-audit-2026-10-14/followup/README.md. No publication approval or independent clinical validation is claimed. Publication authorization 2026-10-15: the site owner requested the website update for the magnesium demo and then instructed “ok, go ahead”. This focused release covers magnesium revision 6 and its supporting references only. Sources and cautious framing were checked against the maintained audit receipts and primary records. Publication approval is not independent clinical validation.